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314Multiple trials demonstrate that for functional MR (ischemic or
nonischemic), surgery with revascularization or mitral valve repair or
replacement does not improve the 5-year survival rate (4). The only
therapies that are beneﬁcial for functional MR are those that
improve ventricular function such as beta-blockers and angiotensin-
converting enzyme inhibitors. Until now, moderate MR has been
deﬁned by an EROA of 0.20 to 0.39 mm2. Patients with 3þ to 4þ
MR who have moderate (2þ) residual MR after placement of a
MitraClip (Abbott Vascular, Abbott Park, Illinois) have reverse
remodeling, a decrease in LV end-diastolic volume from 159 ml to
141 ml (p < 0.001), a trend toward a decrease in end-systolic vol-
ume from 82 ml to 77 ml (p ¼ 0.07), and improvement in symp-
toms after 1 year (5). However, according to the recent ESC criteria,
patients with moderate functional MR would be classiﬁed inap-
propriately as having severe MR and would be candidates for further
intervention.
With the development of percutaneous techniques, there may be
an inclination to treat less severe degrees of MR in an attempt to
improve the status of patients with impaired LV function. However,
this approach is likely to be problematic. It will be difﬁcult to assess
improvement or treatment success (a decrease in MR) if patients
with an EROA of 20 to 30 mm2 are treated. Clinical follow-up and
assessment of improvement will be complicated by the patients’
underlying LV dysfunction. At present, if the criteria for MR
severity are to be reduced in the setting of functional disease, an
EROA threshold of 30 mm2 would be more amenable to deter-
mining whether the intervention reduced MR severity. With an
EROA between 20 and 30 mm2, it will be difﬁcult to discern
whether the intervention actually decreased MR severity, and even
more so if the EROA is 20 to 25 mm2. It is also important not to
use a single variable but to maintain the matrix of echocardiographic
Doppler parameters listed in Table 1, which have been the standard
used to deﬁne MR severity.
Any degree of MR worsens patient prognosis; however, mitral
valve surgery does not improve prognosis unless LV function is
improved. MitraClip patients with a 2þ (moderate) MR result have
an improvement in symptoms, functional capacity, and ventricular
size. These ﬁndings suggest that moderate MR (EROA of >0.20
and <0.30 cm2) does not adversely affect either the left ventricle or
patient prognosis and should not be classiﬁed as severe, despite the
most recent ESC guideline/recommendations (1).
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Physical Exercise Reduces
Aortic Regurgitation
Exercise Magnetic Resonance Imaging
In patients with aortic regurgitation (AR), exercise testing plays a
pivotal role in clinical decision making according to American
College of Cardiology/American Heart Association guidelines.
However, it is unclear exactly how AR behaves during exercise, as it
has only been estimated but not measured so far. Using cardiac
magnetic resonance (CMR), it is theoretically possible to measure
AR and cardiac volume changes during exercise. Studies in patients
with other cardiac diseases have combined exercise and CMR by
using complex, cumbersome, and expensive ergometers (1–3).
Therefore, the ﬁrst aim of this study was to establish a simple and
adequate form of exercise during CMR studies. We designed a
steady-state submaximal exercise test, because it is known that most
hemodynamic changes occur at submaximal exercise levels (4).
Additionally, acquiring blood-ﬂow and cardiac-volume data byCMR
requires a certain amount of time during a hemodynamic steady-state.
The second aim of this study was to investigate the change of AR
and left ventricular (LV) volumes during steady-state submaximal
exercise in patients with asymptomatic isolated AR without any
cardiac medication.
To this end, we designed and built an exercise apparatus (patent
utility no. 202013006749.7) to easily enable steady-state submaxi-
mal exercise over longer periods of time during CMR scanning. The
apparatus is intrinsically auto-normative, as the workload depends
only on the length and weight of the subject’s legs, which are
attached to a rope passing over a pulley ﬁxed to a specially designed
aluminum frame mounted onto the magnetic resonance table. The
patients stroke their legs 72 times/min as directed by a metronome.
Healthy volunteers underwent 2 cardiopulmonary tests to
determine steady-state submaximal and peak oxygen uptake (VO2)
by the new submaximal exercise apparatus and by routine symptom-
limited maximal bicycle exercise. Submaximal VO2 was median 24%
(range 17% to 37%) of peak VO2 (8.6 ml/kg/min [range 7.2 to 13.7
ml/kg/min] and 40 ml/kg/min [range 33 to 54 ml/kg/min]).
Table 1. Hemodynamics at Rest and During Steady State Submaximal Exercise of Patients With Isolated Aortic Regurgitation and
Healthy Volunteers
Healthy Volunteers (n [ 12)
Patients With Isolated Aortic
Regurgitation (n [ 12)
Age, yrs 25 (19–38) 22 (10–40)
Weight, kg 70 (53–95) 64 (29–83)
Rest
Steady State Submaximal
Exercise p Value Rest
Steady State Submaximal
Exercise p Value
Heart rate, beats/min 64 (57–91) 90 (71–115) 0.002 72 (57–87) 90 (76–135) 0.002
Systolic blood pressure, mm Hg 110 (102–126) 126 (104–143) 0.002 111 (97–134) 121 (99–160) 0.026
Diastolic blood pressure, mm Hg 60 (51–81) 73 (43–94) 0.003 53 (42–65) 64 (56–90) 0.005
LVEDV, ml/m2 73 (59–99) 74 (53–100) 118 (52–193) 102 (54–173) 0.004
LVESV, ml/m2 20 (15–34) 19 (13–32) 38 (18–66) 27 (14–51) 0.009
LVEF, % 73 (61–80) 72 (62–80) 68 (58–73) 71 (65–83) 0.021
Cardiac index, l/min/m2 3.6 (2.9–5.0) 4.6 (3.7–6.6) 0.002 3.0 (1.8–6.0) 4.8 (2.6–7.6) 0.004
Net antegrade ﬂow, ml 103 (86–128) 95 (83–138) 112 (51–239) 103 (49–256)
Aortic regurgitation, % d d 35 (9–64) 16 (7–42) 0.003
Values are median (range).
LVEDV ¼ left ventricular end diastolic volume; LVEF ¼ left ventricular ejection fraction; LVESV ¼ left ventricular end systolic volume.
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315To investigate the change of AR and LV volumes, all healthy
volunteers and patients with isolated AR were studied by a standard
cardiac 1.5-T CMR scanner during rest and steady-state submaxi-
mal exercise. LV end-diastolic and end-systolic volumes and aortic
forward and backward ﬂow were measured in a routine fashion, as
previously described (5) (Table 1).
In patients with isolated AR, the amount of AR decreased clearly
and uniformly during exercise. This ﬁnding may impact clinical
decision making, because according to American College of Car-
diology/American Heart Association guidelines, exercise testing is
used as a selection criterion to provoke symptoms during exercise.
However, as shown in our study, AR decreases during exercise.
Additionally, AR at rest correlated with increase of cardiac index
during submaximal exercise (R2 ¼ 0.64; p ¼ 0.001).
We believe that submaximal exercise is an important, but underused,
tool to study hemodynamic changes if myocardial perfusion is not the
objective, because most hemodynamic changes occur at lower levels of
exercise (4). Furthermore, submaximal exercise offers longer observation
time and can be tolerated by ill patients.
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Transcatheter Solution for
Pure Aortic Insufﬁciency
Surgically untreated aortic insufﬁciency (AI) is associated with a 10-
year mortality rate of 34% and the development of signiﬁcant heart
failure in 50% of patients (1). Approximately 10% of AI patients are
not offered surgery, mainly due to age or signiﬁcant comorbidities
(2). Transcatheter aortic valve implantation is an established and
growing technology for calciﬁed aortic stenosis. Calcium on the
aortic valve leaﬂets and annulus is used to anchor the transcatheter
heart valve (THV). However, pure AI lacks calciﬁcation with which
to anchor the THV with ongoing dilation of the aortic annulus,
promoting valve malposition or embolization (Figs. 1A to 1C).
With no dedicated system on the horizon, off-label THVs have
been implanted in selected high-risk patients with pure AI. Valves
are oversized (3), risking annular rupture, to help anchoring. A
